Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2025)
Fennec Pharmaceuticals (FENC) posted Gross Margin of 87.2% for Q4 2025, down 7.93% on a QoQ basis from 94.7% in Q3 2025, and down 436.0% year-over-year from 25.95% in Q4 2024.
Fennec Pharmaceuticals (FENC) Gross Margin (2023 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Gross Margin history runs 3 years deep, the most recent figure standing at 87.2% for Q4 2025.
- Quarterly Gross Margin fell 436.0% year-over-year to 87.2% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 91.57% (down 173.0% YoY) and the FY2025 annual result came in at 91.57%, down 173.0% from the prior year.
- Gross Margin was 87.2% for Q4 2025 at Fennec Pharmaceuticals, down from 94.7% in the prior quarter.
- Across five years, Gross Margin topped out at 97.83% in Q1 2024 and bottomed at 80.54% in Q3 2024.
- A 3-year average of 92.25% and a median of 93.65% in 2023 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2024 — Gross Margin sank 1438 bps — and 2025, when it jumped 1416 bps.
- Fennec Pharmaceuticals' Gross Margin stood at 92.96% in 2023, then declined by 2 bps to 91.56% in 2024, then decreased by 5 bps to 87.2% in 2025.
- Business Quant data shows FENC's Gross Margin at 87.2% in Q4 2025, 94.7% in Q3 2025, and 89.98% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 88.95% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 86.85% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 91.79% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 90.68% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | 87.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 87.20% |
| Sep 30, 2025 | 94.70% |
| Jun 30, 2025 | 89.98% |
| Mar 31, 2025 | 95.74% |
| Dec 31, 2024 | 91.56% |
| Sep 30, 2024 | 80.54% |
| Jun 30, 2024 | 91.63% |
| Mar 31, 2024 | 97.83% |
| Dec 31, 2023 | 92.96% |
| Sep 30, 2023 | 94.92% |
| Jun 30, 2023 | 95.55% |
| Mar 31, 2023 | 94.34% |